Navigating the New Era of Major Depressive Disorder Treatment: Expert Opinions on Rapid Acting Therapies

Experts in the management of mood disorders discuss the current healthcare perception of major depressive disorder, focusing on how to navigate the expanding treatment landscape and provide insight into current treatment practices and approaches for this condition.

EP. 1: Healthcare Perception of Major Depressive Disorder

June 30th 2023

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, comment on the perception of major depressive disorder (MDD) within the healthcare community and the clinical and practical implications of is this condition.

EP. 2: Undertreatment in Patients Suffering From MDD

June 30th 2023

Practitioners discuss the rates of undertreatment in patients suffering from major depressive disorder (MDD).

EP. 3: Tailoring Treatments for Patients With MDD

July 5th 2023

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, discuss navigating the challenge of a “one size fits all approach” when treating and identifying the specific needs of patients with major depressive disorder (MDD).

EP. 4: MDD as a Chronic Condition

July 5th 2023

Experts discuss how practitioners are viewing major depressive disorder (MDD) as a chronic condition vs an episodic condition.

EP. 5: Approach to Treatment in Patients with MDD

July 12th 2023

Practitioners discuss their approach to treatment with their patients with major depressive disorder (MDD).

EP. 6: MDD Treatment: Follow-Up

July 12th 2023

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, discuss best practices for monitoring and follow-up with patients with major depressive disorder (MDD) to ensure treatment efficacy and safety.

EP. 7: MDD Remission

July 19th 2023

Practitioners discuss the need to treat patients with major depressive disorder (MDD) to a complete remission vs a decline in symptomology.

EP. 8: Treatment Switch for MDD

July 19th 2023

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, discuss the typical strategies for switching therapies for major depressive disorder (MDD).

EP. 9: New Classes of Treatment for MDD

July 26th 2023

Experts provide an overview of novel treatments, including glutamatergic, GABAergic, and psychedelic drugs, that are either approved or currently being evaluated in clinical studies for MDD (major depressive disorders).

EP. 10: Practice Pearls for Optimizing MDD Treatment

July 26th 2023

Greg Mattingly, MD, and Jeremey Schreiber, MSN, PMHNP-BC, provide their practice pearls for community psychiatrists and psychiatric nurse practitioners who care for patients with major depressive disorder (MDD) to optimize their treatment and management.